FDANews
FDAnews Device Daily Bulletin

RenovaCare Reveals Positive Results on SkinGun

May 6, 2016

RenovaCare has released positive results from studies conducted by the Berlin-Brandenburg Center for Regenerative Therapies that evaluated its CellMist and SkinGun technologies.

The results show human stem cells sprayed with the SkinGun device maintained 97.3 percent viability.

The device is indicated for regenerating skin burns, wounds and cosmetic applications. — Anisa Jibrell

 

View More Stories